ADHD 诊断：一场关于“存在性”的商业共谋ADHD Diagnosis: A Commercial Complicity of Existence
很多人在寻求 ADHD 诊断却拒绝治疗，这在精神科医生眼里是“迷思”，但在存在性战争的视角下，这是极其精准的博弈。当一个人在高度异化的现代生产力体系中感到失能时，他需要的不是药物来强行适配那个 restrictive norm，而是一个合法的、被医学背书的“身份”来解释自己的痛苦。这里的 ADHD 诊断已经从 medical condition 变成了 identity 补丁：它提供了一种叙事，让个体可以将“无法专注”从个人失败转化为生物学事实，从而在社会评价体系中获得某种豁免权或 cachet。
这背后是一场典型的商业共谋。私人诊所通过 commoditised 的诊断流程，将“标签”作为产品出售。对公司而言，这是最简单的 profit model；对消费者而言，这是最快捷的认知入口。双方共同完成了一次交易：消费者用金钱换取一个能够抵御结构性暴力的身份护盾，而私人医疗机构则在 NHS 失能的结构性漏洞中通过贩卖“确定性”获利。这种共谋将医疗行为异化成了身份认同的消费升级。
最讽刺的是，这种“身份化”反而加剧了文化层面的暴力。正如文中提到的 double stigma，当 ADHD 被滥用为一种身份标签，真正具有生物学障碍的人反而被卷入了一场关于“谁才是真患者”的纯洁性战争。这种叙事权力的争夺并没有削弱任何结构性暴力，反而让医疗资源在私有化市场的操纵下进一步失衡。所谓的“认知增强”讨论，本质上是资本试图将人类大脑进一步工具化的尝试，而我们却在讨论是否该给这个工具贴上一个名为“疾病”的标签。
The rising trend of seeking ADHD diagnosis without treatment is viewed as a 'myth' by psychiatrists, but in the context of existential war, it is a precise strategic move. In a hyper-alienated productivity system, individuals aren't seeking medication to fit into a restrictive norm; they are seeking a legitimate, medically-backed 'identity' to explain their suffering. ADHD has shifted from a medical condition to an identity patch. It provides a narrative that transforms 'inability to focus' from personal failure into a biological fact, granting the individual a form of exemption or cachet within the social evaluation system.
This is a classic case of complicity. Private providers have commoditised the diagnostic process, selling 'labels' as products. For the companies, it is a simple profit model; for the consumers, it is the fastest cognitive entry to a new identity. They complete a transaction where the consumer trades money for an identity shield to ward off structural violence, while private clinics profit from the structural gaps left by a failing NHS. This complicity alienates medical practice into a form of consumerist identity upgrading.
Ironically, this 'identification' exacerbates cultural violence. As ADHD becomes a trendy identity, those with actual biological impairments are dragged into a purity war over who has 'real' ADHD. This struggle for narrative power does nothing to dismantle structural violence; it only further imbalances medical resources under the manipulation of a privatised market. The debate over 'cognitive augmentation' is simply an attempt by capital to further instrumentalise the human brain, while we argue over whether to label that instrument as a 'disorder'.